These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 29474204)

  • 61. [The Risk Factors of Thrombosis in Patients with Philadelphia Chromosome-negative Myeloproliferative Neoplasms].
    Zhao YF; Lin SZ; Bai X; Xing XY; Tao HF; Su YZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Dec; 29(6):1869-1874. PubMed ID: 34893125
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Antiphospholipid antibodies and the risk of thrombosis in myeloproliferative neoplasms.
    Dambrauskienė R; Gerbutavičius R; Rudžianskienė M; Paukštaitienė R; Vitkauskienė A; Skrodenienė E; Remeikienė D; Zaborienė I; Juozaitytė E
    Open Life Sci; 2023; 18(1):20220545. PubMed ID: 36816798
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Elevated plasma levels of procoagulant microparticles are a novel risk factor for thrombosis in patients with myeloproliferative neoplasms.
    Taniguchi Y; Tanaka H; Luis EJ; Sakai K; Kumode T; Sano K; Serizawa K; Rai S; Morita Y; Hanamoto H; Tsubaki K; Nishio K; Matsumura I
    Int J Hematol; 2017 Nov; 106(5):691-703. PubMed ID: 28780601
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clinical Features of 294 Turkish Patients with Chronic Myeloproliferative Neoplasms.
    Andıç N; Ünübol M; Yağcı E; Akay OM; Yavaşoğlu İ; Kadıköylü VG; Bolaman AZ
    Turk J Haematol; 2016 Sep; 33(3):187-95. PubMed ID: 27094255
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Antecedent cardiovascular disease and autoimmunity in Philadelphia-negative chronic myeloproliferative neoplasms.
    Sørensen AL; Hasselbalch HC
    Leuk Res; 2016 Feb; 41():27-35. PubMed ID: 26718091
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The Impact of Mean Platelet Volume (MPV) and JAK-2 Mutation on Thrombosis in Chronic Myeloproliferative Diseases.
    Ayer M; Menken İ; Yamak M; Ayer FA; Kırkızlar O; Burak Aktuğlu M
    Indian J Hematol Blood Transfus; 2017 Jun; 33(2):181-187. PubMed ID: 28596648
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Platelet distribution width and mean platelet volume in idiopathic pulmonary arterial hypertension.
    Zheng YG; Yang T; Xiong CM; He JG; Liu ZH; Gu Q; Zhao ZH; Ni XH
    Heart Lung Circ; 2015 Jun; 24(6):566-72. PubMed ID: 25573235
    [TBL] [Abstract][Full Text] [Related]  

  • 68. An Increase in Mean Platelet Volume/Platelet Count Ratio Is Associated with Vascular Access Failure in Hemodialysis Patients.
    Shin DH; Rhee SY; Jeon HJ; Park JY; Kang SW; Oh J
    PLoS One; 2017; 12(1):e0170357. PubMed ID: 28095482
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Significance of the JAK2V617F mutation in patients with chronic myeloproliferative neoplasia].
    Iványi JL; Marton E; Plander M
    Orv Hetil; 2011 Nov; 152(45):1795-803. PubMed ID: 22011365
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Predictive Effect of Mean Platelet Volume in Patients with Portal Vein Thrombosis: A Meta-analysis of Case-control Studies.
    Lin WY; Lu X; Fan FJ; Hu Y
    Curr Med Sci; 2018 Aug; 38(4):575-581. PubMed ID: 30128864
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Patients with myeloproliferative neoplasms and COVID-19 have increased rates of arterial thrombosis.
    Leiva O; Campia U; Snyder J; Barns BM; Rizzo S; Khairani CD; Brunner A; Al-Samkari H; Leaf RK; Rosovsky R; Goodarzi K; Bornikova L; Fathi A; Goldhaber SZ; Hobbs G; Piazza G
    Res Pract Thromb Haemost; 2022 Jul; 6(5):e12752. PubMed ID: 35979196
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Molecular characterization of Ph-negative myeloproliferative neoplasms in Ukraine.
    Mishcheniuk OY; Kostukevich OM; Dmytrenko IV; Sholoyko VV; Prokopenko IM; Martina ZV; Pilipenko GV; Klymenko SV
    Exp Oncol; 2013 Sep; 35(3):202-6. PubMed ID: 24084459
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Management of venous thromboembolism in myeloproliferative neoplasms.
    Barbui T; De Stefano V
    Curr Opin Hematol; 2017 Mar; 24(2):108-114. PubMed ID: 27875375
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Analysis of risk factors predicting thrombotic and/or haemorrhagic complications in 306 patients with essential thrombocythemia.
    Radaelli F; Colombi M; Calori R; Zilioli VR; Bramanti S; Iurlo A; Zanella A
    Hematol Oncol; 2007 Sep; 25(3):115-20. PubMed ID: 17464935
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A population-based study of an Italian genetic isolate reveals that mean platelet volume is not a risk factor for thrombosis.
    Biino G; Portas L; Murgia F; Vaccargiu S; Parracciani D; Pirastu M; Balduini CL
    Thromb Res; 2012 Apr; 129(4):e8-13. PubMed ID: 22137741
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Characterization of patients with Philadelphia negative myeloproliferative neoplasms and concomitant monoclonal gammopathies: Just coincidence?].
    Corsini F; Peña C; Gajardo C; Goldschmidt V; Avendaño C; Contreras N; Bahamonde Á; Zambrano D; Graffigna P; Lizama V; Valladares X
    Rev Med Chil; 2023 Nov; 151(11):1501-1505. PubMed ID: 39270117
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Busulfan is effective second-line therapy for older patients with Philadelphia-negative myeloproliferative neoplasms intolerant of or unresponsive to hydroxyurea.
    Douglas G; Harrison C; Forsyth C; Bennett M; Stevenson W; Hounsell J; Ratnasingam S; Ritchie D; Ross DM; Grigg A
    Leuk Lymphoma; 2017 Jan; 58(1):89-95. PubMed ID: 27454522
    [TBL] [Abstract][Full Text] [Related]  

  • 78. JAK2V617F mutation screening as part of the hypercoagulable work-up in the absence of splanchnic venous thrombosis or overt myeloproliferative neoplasm: assessment of value in a series of 664 consecutive patients.
    Pardanani A; Lasho TL; Hussein K; Schwager SM; Finke CM; Pruthi RK; Tefferi A
    Mayo Clin Proc; 2008 Apr; 83(4):457-9. PubMed ID: 18380991
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Incidence and impact of atrial arrhythmias on thrombotic events in MPNs.
    Mahé K; Delluc A; Chauveau A; Castellant P; Mottier D; Dalbies F; Berthou C; Guillerm G; Lippert E; Ianotto JC
    Ann Hematol; 2018 Jan; 97(1):101-107. PubMed ID: 29164292
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Mean platelet volume: a link between thrombosis and inflammation?
    Gasparyan AY; Ayvazyan L; Mikhailidis DP; Kitas GD
    Curr Pharm Des; 2011; 17(1):47-58. PubMed ID: 21247392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.